Allergy and Asthma Proceedings

Papers
(The TQCC of Allergy and Asthma Proceedings is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Hereditary angioedema: Epidemiology and burden of disease72
The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?56
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome55
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-235
Definition and classification of hereditary angioedema31
COVID-19 in children: Pathogenesis and current status31
Triggers and short-term prophylaxis in patients with hereditary angioedema28
Patient perspectives on the treatment burden of injectable medication for hereditary angioedema28
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination27
Treatment strategies for postviral olfactory dysfunction: A systematic review27
Clinical presentation of hereditary angioedema24
Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation23
The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome23
COVID-19 in a patient with severe asthma using mepolizumab23
Hereditary angioedema: Special considerations in women22
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)22
Hereditary angioedema: Differential diagnosis, diagnostic tests, and family screening21
Hereditary angioedema and shared decision making21
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic20
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?20
Hereditary angioedema: On-demand treatment of angioedema attacks20
Psychology and hereditary angioedema: A systematic review19
Hereditary angioedema: Special considerations in children18
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines18
Effect of COVID-19 on hereditary angioedema activity and quality of life18
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis18
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies18
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study18
Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies17
Hereditary angioedema: Long-term prophylactic treatment17
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications17
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 201917
Assessing the cost and quality-of-life impact of on-demand‐only medications for adults with hereditary angioedema17
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis16
Shifts in allergy practice in a COVID-19 world: Implications of pre‐COVID-19 national health care provider and patient surveys of treatments for nasal allergies16
Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs16
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation16
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy16
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience16
Treatment options for chronic rhinosinusitis with nasal polyps15
Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema15
Tropomyosin: A panallergen that causes a worldwide allergic problem15
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance15
Atopic dermatitis: Correlation of severity with allergic sensitization and eosinophilia14
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management14
Safety of subcutaneous allergen immunotherapy14
Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations14
Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria14
Hereditary angioedema: Investigational therapies and future research13
Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study13
Hereditary angioedema: Comprehensive management plans and patient support13
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol13
Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction12
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs12
Caregivers’ role in managing hereditary angioedema and perceptions of treatment-related burden12
Efficacy and safety of sublingual allergen immunotherapy12
Asthma in pregnancy12
Accelerated/rush allergen immunotherapy12
Idiopathic anaphylaxis: Diagnosis and management11
Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease11
Novel diagnostic techniques and therapeutic strategies for IgE‐mediated food allergy11
Weighing the benefits and risks of oral immunotherapy in clinical practice11
Phenotypes and natural history of food protein‐induced enterocolitis syndrome in the east Mediterranean region11
Delayed allergic skin reactions to vaccines10
The long COVID syndrome: A conundrum for the allergist/immunologist10
Serum levels of specific immunoglobulin E toDermatophagoides pteronyssinusallergen components in patients with allergic rhinitis or/and asthma10
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease10
Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis10
Considerations for asthma management and viral transmission in the era of COVID-199
Patient perspectives on penicillin allergy and testing9
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis9
COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results9
Clinical implications of asthma endotypes and phenotypes9
Evaluation of drug patch tests in children9
Long-term adherence strategies for allergen immunotherapy9
Allergy to oak pollen in North America9
Guidelines for management of hereditary angioedema: What is new? What is missing?9
Short-term prophylaxis for children and adolescents with hereditary angioedema9
Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria8
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?8
Longitudinal experience with treatment of acquired angioedema using tranexamic acid8
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children8
A 2-year-old girl with periprocedural anaphylaxis8
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes8
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course8
A 48-year-old female with perioperative anaphylaxis8
Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia8
Paucigranulocytic asthma: Do sputum macrophages matter?8
Epinephrine autoinjector prescription filling after pediatric emergency department discharge8
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis8
Allergen immunotherapy and shared decision-making8
Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis8
Cat allergy in children and the effect of the COVID-19 pandemic8
56-year-old male with HIV and sudden cardiac arrest7
How satisfactory is on-demand icatibant from the patients' perspective in real life?7
Ideal body position for epinephrine autoinjector administration7
COVID-19 in Italian children and adolescents: The role of allergy and asthma7
Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions7
A 62-year-old man with new-onset bullae7
Female sex as a risk factor for penicillin drug allergy in the inpatient setting7
Venom allergen immunotherapy7
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema7
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose7
Peanut allergy in an adult following cardiac transplant from a non-atopic donor7
A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children7
Primary immunodeficiency diseases treated with immunoglobulin and associated comorbidities7
0.08195686340332